MTOR and endometriosis: In fact, dienogest, which is a progestin drug approved for endometriosis treatment, works by downregulating mTOR signaling, and specifically by repressing the activity of ERK1/2 and AKT, thereby promoting apoptosis and autophagy in human endometriotic cyst stromal cells [50].